The following is a summary of “Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study,” published in the January 2025 issue of Ophthalmology by ...
AI Optics, a biotech startup backed by NYU Langone and raising in stealth, announced clearance this week from the Food and ...
As a retina specialist, one of the most important aspects of eye care I focus on is the prevention and treatment of diabetic retinopathy. This condition is a leading cause of blindness in adults, yet ...
EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...
EyePoint Pharmaceuticals Inc. (EYPT), which reported positive interim 16-week data from its phase II VERONA clinical trial last ...
The most common reason given in interviews for not attending a diabetic eye screening appointment related to mental health ...
ALAN CARR fears an eye condition will ruin his eyesight after having a “worrying” diagnostic test. The 48-year-old Chatty Man ...
Active Biotech (NASDAQ STOCKHOLM: ACTI) today announced that the US Patent Office (USPTO) has granted Active Biotech's US patent application 17/939,109 for laquinimod in eye disorders. "We ...
Time-in-range computed from virtual CGM data predicts retinopathy, neuropathy similarly to glycated hemoglobin data ...
Financial 27.01.2025 / 14:04 CET/CEST The issuer is solely responsible for the content of this announcement. LAS VEGAS - January 27, 2025 (NEWMEDIAWIRE) - Avant Technologies, Inc. (OTCQB: AVAI) ...
Three experts discuss the increased mortality risk for patients with diabetic retinopathy, available screening tools, and counseling patients during eye exams.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback